Overjet
Overview
Overjet is a leading dental artificial intelligence company that leverages cutting-edge technology to transform the dental care industry. Founded in 2018 by experts from MIT and Harvard University, Overjet is headquartered in Boston, Massachusetts. It empowers dentists and insurers with AI tools to detect oral pathologies with unmatched precision and streamline workflows. Overjet has raised a significant amount of funding, totaling approximately $133 million as of March 2024. The company has been recognized globally for its innovative solutions and impact in the healthcare sector.
Recent Developments
- August 6, 2024: Overjet launched its first AI-powered analytics suite specifically for Dental Support Organizations (DSOs), enhancing decision-making and operational efficiencies.
- July 23, 2024: Dental Care Alliance announced a collaboration with Overjet, rolling out its AI technology across more than 400 practices in the United States.
- July 11, 2024: Overjet integrated with CareStack, offering AI tools for improved X-ray analysis in dental practices, thus simplifying diagnostic accuracy and clinical workflows.
- March 5, 2024: Overjet raised $53.2 million in a Series C funding round, which is the largest investment in the history of dental AI. This financing will help in expanding Overjet's platform capabilities.
- September 2023: Overjet was named one of LinkedIn's Top Startups in the United States, reflecting its rapid growth and impact in the dental AI space.
- June 7, 2023: Overjet expanded its AI capabilities with new FDA clearances, enhancing functionality for X-ray analyses.
- January 2023: Partnerships with major players in the dental industry, like DECA Dental Group, were established to broaden the use of Overjet’s AI in dental practices.
Company Information
| Attribute | Information |
|---|---|
| Founding Date | 2018 |
| Headquarters | Boston, Massachusetts |
| Founders | Wardah Inam, Alexander Jelicich, Deepak Ramaswamy |
| Revenue | Not publicly disclosed |
| Profits | Not publicly disclosed |
| Key Investors | March Capital, General Catalyst, E14 Fund |
| Industry | Dental Artificial Intelligence |
| Number of Employees | Approximately 193 (as of 2024) |
Early History
Overjet was founded in 2018 with the aim of addressing the variability in dental diagnostics and treatment recommendations through advanced AI technology. The company originated at Harvard Innovation Labs when a team of computer scientists from MIT and dentists from Harvard University recognized the potential of AI in dentistry. Early on, Overjet focused on developing a platform that could interpret dental images to aid diagnosis and streamline claim approvals. The pursuit of FDA clearance for its AI technology was a significant milestone, setting the standard for AI-driven dental care.
Company Profile and Achievements
Overjet has made significant strides in the dental AI industry by developing a platform that automates the analysis of dental X-rays, identifies pathologies with precision, and optimizes both provider and payer workflows. The company's technology is the first in dental AI to receive FDA clearance, underscoring its pioneering role in dental diagnostics.
- Core Products: Overjet offers two main platforms—Clinical Intelligence for providers, enhancing patient care by identifying pathologies in X-rays with AI, and Insurance Intelligence, which accelerates claims processing and reduces administrative burdens.
- Key Milestones:
- Received multiple FDA clearances for AI technologies, enhancing capabilities for detecting dental pathologies.
- Secured $133 million in funding across several rounds to fuel expansion and innovation efforts.
- Built a robust partnership network with major dental organizations and insurers, covering over 120 million members in the U.S.
Current Operations and Market Position
Today, Overjet is positioned as a leader in dental AI, serving thousands of dental practices and partnering with major dental insurers. Its AI tools not only enhance diagnostic precision but also support operational efficiencies in dental practices. Overjet’s market edge lies in its FDA-cleared technology, extensive clinical validation, and ability to integrate seamlessly into existing clinical workflows. The company's focus on a patient-centric model is driving innovations that connect dental providers and insurers, improving patient and provider experiences across the board.
Conclusion
Overjet stands at the forefront of dental AI innovation, offering transformative technologies that improve diagnostic accuracy and streamline dental care processes. With substantial backing from prominent investors and a strong rapport with dental care providers and insurers, Overjet is poised to expand its impact in the dental industry. The company’s focus on leveraging AI as a unifying force in dental care positions it for continued growth and leadership in advancing global oral health solutions.